+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cytology Brushes Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)

  • PDF Icon


  • 119 Pages
  • April 2023
  • Region: Global
  • Mordor Intelligence
  • ID: 5529282
UP TO OFF until Dec 31st 2023

Quick Summary:

Operating within an ever-evolving sector, give yourself the competitive edge and adapt to the dynamism and intricacies of the healthcare environment with the purchase of this vital cytology brushes market report. Stay ahead of the curve with comprehensive, actionable insights, gathered through rigorous exploration of current industry trends and projections for future market strategies.

Understand the drivers behind market growth such as the increasing prevalence of chronic diseases, and the correlating demand for early detection to ensure tailored medical treatment. Discern how influences such as the rising number of cervical cancer cases, escalating respiratory diseases, and the resultant demand for cytology brushes contribute to shaping the market trajectory. Additionally, ascertain the challenges and opportunities in the industry, keeping abreast of the influence of complexities such as the sensitivity of cytology tests on future market growth.

Seize the opportunity to assess the cytology brushes market from a macroscopic lens, with detailed breakdowns of impactful segments like gynecology and geographically dominant regions like North America. Grasp an expert's perspective on the key industry players and their innovative strategies set to define market trends.

The cytology brushes market is expected to register a CAGR of 5.2% over the forecast period.

The 2019 Coronavirus Disease (COVID-19) has had a significant influence on the provision of healthcare globally and has altered the practice of pathology, especially cytology. According to the study published in the International Journal of Health and Clinical Research in January 2022, the overall number of cases of cytology significantly decreased throughout the COVID era, and statistically significant drops in sample numbers in the categories of thyroid and lymphoma were seen. As a result of the aforementioned characteristics, COVID-19 significantly impacted the cytology brushes market. Additionally, the market is growing again as all of the activities return to normal and are expected to follow the same trend over the forecast period.

The growing prevalence of chronic diseases, such as respiratory diseases, urological disorders, and cancer, and increasing emphasis on early detection, are some of the factors expected to drive the overall market growth. According to the World Health Organization Updates in February 2022, cervical cancer is the fourth most common cancer in women worldwide, with 604 000 new cases and 342 000 deaths by 2020. Thus, the growing prevalence of cervical cancer is expected to drive the demand for cytology brushes for the examination of cervical cancer cells.

Additionally, the growing prevalence of respiratory diseases is likely to support the growth of the market over the forecast period. The data updated by the Centres for Disease Control and Prevention (CDC) in September 2022 mentioned that 873,000 emergency department visits with COPD were reported in 2020 in the United States, and 5% of adults were diagnosed with COPD, emphysema, or chronic bronchitis for the first time. Lung abnormalities are diagnosed using respiratory tract cytology. It also participates in a variety of infectious and inflammatory processes, which is anticipated to fuel demand for cytology brushes and accelerate the market's expansion over the forecast period.

Thus, all the above-mentioned factors are expected to boost market growth over the forecast period. However, the low sensitivity of cytology tests may restrain the market growth over the forecast period.

Cytology Brushes Market Trends

The Gynecological Segment is Expected to Hold a Significant Share in the Studied Market Over The Forecast Period.

The gynecological segment is expected to hold a significant share of the cytology brush market through the forecast period. The growing prevalence of gynecological diseases and conditions, such as cervical cancer, uterine cancer, vaginal melanoma, extended bleeding, and irregular menstrual cycles, are primarily resulting in increased demand for cytology brushes in gynecology disorder diagnosis and treatments. According to the Cancer Council updated in 2021, in Australia, 913 cases of cervical cancer were diagnosed in 2021. Thus, the growing prevalence of cervical cancer is expected to rise in demand for its diagnosis and cytological examination, thereby boosting segment growth.

Moreover, to increase the research and development of gynecological cancer research, research institutes have implemented various strategies such as seminars and poster presentations to introduce different ideas from academics and clinicians in order to grow gynecological research activities. For instance, in September 2022, the Rivkin Center for Ovarian Cancer and the American Association for Cancer Research is presenting the 'Virtual Ovarian Cancer Research Series.' The seminar series aims to bring together academics and clinicians from various institutions and disciplines from across the world to exchange ideas and develop the field of ovarian cancer research.

Thus, all aforementioned factors are expected to boost the growth of the segment over the forecast period.

North America Dominates the Market and Expected to do Same in the Forecast Period.

North America dominates the market, and it is expected to maintain its dominance throughout the forecast period. Significant awareness about chronic ailments and regular health screening, favorable government reimbursement policies, and availability of sophisticated healthcare infrastructure is expected to drive the demand for the cytological examination, which in turn will lead to a surge in demand for cytology brushes North American region. According to the American Cancer Society, in 2022, there were around 13,800 new cases of invasive cervical cancer diagnosed, and about 4,290 women died from cervical cancer. Additionally, as per the same source, there are more than 600,000 survivors of endometrial cancer in the United States. As per the same source, around 65,950 new cases of cancer of the body of the uterus (uterine body or corpus) are expected to be diagnosed in 2022. Thus, the growing prevalence of gynecological diseases is expected to rise in demand for cytological examination of gynecological diseases, thereby boosting the demand for cytology brushes over the forecast period.

Furthermore, growing cancer research and development activity is predicted to drive market expansion. It is expected that research on gynecological cancer would likely rise to bring technologically advanced diagnostic tools to market, including cytology brushes. According to National Cancer Institute (NIC) data updated in March 2022, the Consolidated Appropriations Act 2022 allocated USD 6.9 billion to National Cancer Institute (NIC), a USD 353 million net increase over FY 2021. Included in the FY 2022 allocation is USD 194 million in funding for the Cancer Moonshot and USD 50 million for the Childhood Cancer Data Initiative. Such initiatives are encouraging research activity which is likely to support the growth of the market.

Thus, all aforementioned factors are expected to boost the market in the region over the forecast period.

Cytology Brushes Market Competitor Analysis

This industry is highly fragmented, with the presence of several local players. The major players include companies such as Boston Scientific Corporation, Conmed Corporation, Cook, Olympus America, and Telemed Systems Inc. These companies are actively involved in product innovations and technological advancements to ensure better recognition and push product sales.

Additional benefits of purchasing the report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

This product will be delivered within 2 business days.

Table of Contents

1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Chronic Diseases
4.2.2 Technological Advancements in Cytology Brushes
4.3 Market Restraints
4.3.1 Low Sensitivity of Cytology Tests
4.4 Porter Five Forces
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION (Market Size by Value - USD million)
5.1 By Product
5.1.1 Metal Cytology Brushes
5.1.2 Plastic Cytology Brushes
5.2 By Application
5.2.1 Respiratory Tract
5.2.2 Gastrointestinal
5.2.3 Gynecological
5.2.4 Other Applications
5.3 Geography
5.3.1 North America United States Canada Mexico
5.3.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
5.3.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.3.4 Middle-East and Africa GCC South Africa Rest of Middle-East and Africa
5.3.5 South America Brazil Argentina Rest of South America
6.1 Company Profiles
6.1.1 Boston Scientific Corporation
6.1.2 Conmed Corporation
6.1.3 Cook
6.1.4 Cosmomed SA
6.1.5 McKesson Medical-Surgical Inc.
6.1.6 Henry Schein Medical.
6.1.7 Medi-Globe Gmbh
6.1.8 Olympus America
6.1.9 Telemed Systems Inc.
6.1.10 Advin Health Care
6.1.11 Narang Medical Limited

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Boston Scientific Corporation
  • Conmed Corporation
  • Cook
  • Cosmomed SA
  • McKesson Medical-Surgical Inc.
  • Henry Schein Medical.
  • Medi-Globe Gmbh
  • Olympus America
  • Telemed Systems Inc.
  • Advin Health Care
  • Narang Medical Limited